Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
SWOG Cancer Research Network
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
SWOG Cancer Research Network
SWOG Cancer Research Network
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
SWOG Cancer Research Network